YNDX yields 10.56% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 8
Combined, YNDX + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YNDX + MRK for your $10,000?
Yandex N.V., a technology company, builds intelligent products and services powered by machine learning and other technologies to help consumers and businesses navigate the online and offline world. The company operates through Search and Portal, Taxi, Yandex.Market, Media Services, Classifieds, and Other Business Units and Initiatives segments. It provides locally relevant search and information services. The company also develops on-demand transportation, delivery, and navigation services and products, as well as operates in the e-commerce, online entertainment, and cloud computing markets to address the needs of customers in Russia and various international markets. In addition, it operates Yandex.Plus, a subscription loyalty program; offers fintech instruments, such as payment and financial services; and advertising services. Further, the company operates classifieds platforms for the sale of used and new cars, motorcycles, commercial vehicles, and spare parts; and sale and rental of apartments, houses, and commercial property for private individuals, developers, and realtors, as well as a long-term apartment rental platform to manage pre-contract rental processes and subsequent administration of the payments. Additionally, it operates Yandex Zen, a social infotainment platform that brings together content creators and users; and Yandex Cloud, a cloud platform that provides infrastructure, storage, machine learning, and development tools to build and enhance cutting-edge digital services and applications for B2B customers and individual developers. The company was founded in 1989 and is based in Schiphol, the Netherlands.
Full YNDX Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.